A controlled trial of oral dipyridamole in 103 patients with acute myocardial infarction showed no difference in the number of complications or deaths in either the control or the treated groups. It is concluded that dipyridamole has no benefit in acute myocardial infarction.

Acute Disease↗

PubMed1968

Effect of frusemide, lactose, and urea on urinary cell loss.

With the use of a staining method by which cells in the urine can be differentiated, the effect of oral frusemide, lactose, and urea on the rate of excretion of these cells was investigated in five healthy persons.It is shown that frusemide greatly increases the urinary excretion of red cells, white cells, and renal tubular cells. Similar though not so marked changes were produced by both lactose and urea. Possible reasons for the increased excretion of cells are discussed. One is that it may be the result of an increase in the rate of urinary flow.

Adult↗

PubMedDate not supplied

Adiposity and adipose cells.

Explore the source record for details and available documents.

Adipose Tissue↗

PubMedDate not supplied

Growth and growth hormone therapy in hypochondroplasia.

The growth of 84 patients with hypochondroplasia (56 male, 28 female) was studied. A wide spectrum of severity was found from quite severe short limbed dwarfism to short apparently normal prepubertal children who manifested disproportion only at puberty when growth failed. The onset of puberty was at the normal time but the pubertal growth spurt appeared not to materialize and it is this lack which resulted in severely compromised adult heights of 145-165 cm in boys and 133-151 cm in girls. Twenty (12 M, 8 F) hypochondroplastic children aged between 4.3 and 12.8 years were recruited to a study of the effects of biosynthetic growth hormone. All had normal growth hormone responses (greater than 15 mU/l) to a pharmacological test of growth hormone secretion. Biosynthetic growth hormone in doses between 12-32 mu/m2/week produced a significant acceleration in height velocity standard deviation score (SDS) for chronological age (CA) from a pretreatment mean of -1.66 (SD 1.36) to +1.62 (SD 1.52) (p less than 0.001). Significant increases were also observed in the height SDS for bone age (BA), sitting height (SH) SDS and subischial leg length (SILL) SDS. A longer period will be required to assess the effect of treatment on adult height prognosis.

Adolescent↗